Spyre Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Hand-out
Press Releases
Spyre Therapeutics, Inc.  
November 25, 2024

Spyre Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference

WALTHAM, Mass., Nov. 25, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches to target improved

avatar profile Olean Times Herald

Olean Times Herald


Local & Social